• Webinar recording – Proteogenomic strategies to advance drug development and precision medicine

    Are you interested in gaining new insights into how proteomics and genomics are now increasingly joining forces to improve the  clinical utility of protein biomarkers and to enhance drug development strategies? Olink Proteomics recently sponsored this Science/AAAS webinar:

    Title: “Proteogenomic strategies to advance drug development and precision medicine”

    Date: Wednesday 6th September 2017, 12:00 pm ET/18:00 CET – now available as a recorded  presentation

    Speakers:  Professor Ulf Gyllensten (Uppsala University) & Dr. Anders Mälarstig (Pfizer Sweden)

    During the webinar, the speakers:

    • Discussed how covariates (genetic, environmental, and clinical) can affect the levels of potential biomarkers
    • Explored the use of covariate modeling to establish personally normalized plasma protein profiles (PNPPP) to reduce non-disease-related variation and maximize clinical potential
    • Described how protein quantitative trait loci (pQTLs) can provide insights into disease biology and improve the efficiency of drug development